Advertisement

Archives of Gynecology and Obstetrics

, Volume 300, Issue 3, pp 763–769 | Cite as

Fertility outcomes in patients with tubo-ovarian abscesses after an oocyte retrieval: a longitudinal cohort analysis

  • Yuval Fouks
  • Foad Azem
  • Ariel Many
  • Yoni Cohen
  • Ishai Levin
  • Aviad CohenEmail author
Gynecologic Endocrinology and Reproductive Medicine
  • 55 Downloads

Abstract

Purpose

To determine the impact of pelvic inflammation caused by tubo-ovarian abscess (TOA) on ovarian response to stimulation.

Methods

This retrospective longitudinal cohort analysis that was carried out in a tertiary university-affiliated medical center included 15 women with TOA during in vitro fertilization (IVF) cycles. The ovarian response to stimulation and the pregnancy rate were compared in two subsequent cycles, the initial IVF cycle that was complicated by TOA after oocyte retrieval (first treatment cycle) and the following IVF treatment (second treatment cycle) that occurred within a period of a year from the first cycle.

Results

The mean number of retrieved oocytes was significantly higher in the first IVF cycle compared to the second cycle (8.1 ± 3.2 vs. 5.4 ± 2.5, P = .003], corresponding to a 30% reduction in ovarian response to gonadotropin stimulation. Fertilization rates were significantly lower in the second cycle (4.1 ± 2.9 vs. 2.9 ± 1.7, P = .015). Twelve women (80%) reached embryo transfer in the first cycle compared to 14 women (93.3%) in the second cycle. The mean number of transferred embryos was similar between the two cycles. There were no clinical pregnancies following the first cycle, and only one patient (6.6%) had a clinical pregnancy in the second treatment cycle.

Conclusions

TOA following fertility treatment has a detrimental effect on ovarian function. The pregnancy rate in the immediate period following TOA is poor. Current data for recommending the deferral of fertility treatment following a TOA episode are insufficient, calling for more studies to address these issues.

Keywords

Pelvic inflammatory disease Pelvic abscess Fertility Endometriosis Tuboovarian abscess 

Notes

Author contributions

YF: protocol/project development, data collection or management, manuscript writing/editing, and data analysis. YC: data management, manuscript writing/editing, and data analysis. IL: manuscript writing/editing and data analysis. AM: protocol/project development and manuscript writing/editing. FA: manuscript writing/editing. AC: protocol/project development, manuscript writing/editing, and data analysis.

Compliance with ethical standards

Conflict of interest

All the authors report no conflict of interest and that this research was non-funded.

References

  1. 1.
    Sorbye IK, Jerve F, Staff AC (2005) Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade. Acta Obstet Gynecol Scand 84(3):290–296.  https://doi.org/10.1111/j.0001-6349.2005.00509.x CrossRefGoogle Scholar
  2. 2.
    Granberg S, Gjelland K, Ekerhovd E (2009) The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol 23(5):667–678.  https://doi.org/10.1016/j.bpobgyn.2009.01.010 CrossRefGoogle Scholar
  3. 3.
    Wiesenfeld HC, Sweet RL (1993) Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 36(2):433–444CrossRefGoogle Scholar
  4. 4.
    Pedowitz P, Bloomfield RD (1964) Ruptured adnexal abscess (Tuboovarian) with generalized peritonitis. Am J Obstet Gynecol 88:721–729CrossRefGoogle Scholar
  5. 5.
    Chappell CA, Wiesenfeld HC (2012) Pathogenesis, diagnosis, and management of severe pelvic inflammatory disease and tubo-ovarian abscess. Clin Obstet Gynecol 55(4):893–903.  https://doi.org/10.1097/GRF.0b013e3182714681 CrossRefGoogle Scholar
  6. 6.
    McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB (1998) Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol 178(6):1272–1278CrossRefGoogle Scholar
  7. 7.
    Gjelland K, Ekerhovd E, Granberg S (2005) Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: a study of 302 cases. Am J Obstet Gynecol 193(4):1323–1330.  https://doi.org/10.1016/j.ajog.2005.06.019 CrossRefGoogle Scholar
  8. 8.
    El-Shawarby S, Margara R, Trew G, Lavery S (2004) A review of complications following transvaginal oocyte retrieval for in-vitro fertilization. Hum Fertil (Camb) 7(2):127–133.  https://doi.org/10.1080/14647270410001699081 CrossRefGoogle Scholar
  9. 9.
    Fouks Y, Cohen Y, Tulandi T, Meiri A, Levin I, Almog B, Cohen A (2018) Complicated clinical course and poor reproductive outcomes of women with tubo-ovarian abscess after fertility treatments. J Minim Invasive Gynecol. https://doi.org/10.1016/j.jmig.2018.06.004
  10. 10.
    Timor-Tritsch IE, Lerner JP, Monteagudo A, Murphy KE, Heller DS (1998) Transvaginal sonographic markers of tubal inflammatory disease. Ultrasound Obstet Gynecol 12(1):56–66.  https://doi.org/10.1046/j.1469-0705.1998.12010056.x CrossRefGoogle Scholar
  11. 11.
    Centers for Disease Control and Prevention ASfR, Medicine SfART (2015) 2015 Assisted reproductive technology national summary report. US Department of Health and Human Services, Atlanta. https://www.cdc.gov/art/. Accessed 10 Jan 2017
  12. 12.
    Rosen M, Breitkopf D, Waud K (2009) Tubo-ovarian abscess management options for women who desire fertility. Obstet Gynecol Surv 64(10):681–689.  https://doi.org/10.1097/OGX.0b013e3181b8b0d6 CrossRefGoogle Scholar
  13. 13.
    Landers DV, Sweet RL (1983) Tubo-ovarian abscess: contemporary approach to management. Rev Infect Dis 5(5):876–884CrossRefGoogle Scholar
  14. 14.
    Hemsell DL, Santos-Ramos R, Cunningham FG, Nobles BJ, Hemsell PG (1985) Cefotaxime treatment for women with community-acquired pelvic abscesses. Am J Obstet Gynecol 151(6):771–777CrossRefGoogle Scholar
  15. 15.
    Reed SD, Landers DV, Sweet RL (1991) Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 164(6 Pt 1):1556–1561 (discussion 1561–1552) Google Scholar
  16. 16.
    Henry-Suchet J, Soler A, Loffredo V (1984) Laparoscopic treatment of tuboovarian abscesses. J Reprod Med 29(8):579–582Google Scholar
  17. 17.
    Reich H, McGlynn F (1987) Laparoscopic treatment of tuboovarian and pelvic abscess. J Reprod Med 32(10):747–752Google Scholar
  18. 18.
    Ashkenazi J, Farhi J, Dicker D, Feldberg D, Shalev J, Ben-Rafael Z (1994) Acute pelvic inflammatory disease after oocyte retrieval: adverse effects on the results of implantation. Fertil Steril 61(3):526–528CrossRefGoogle Scholar
  19. 19.
    Barnhart K, Dunsmoor-Su R, Coutifaris C (2002) Effect of endometriosis on in vitro fertilization. Fertil Steril 77(6):1148–1155CrossRefGoogle Scholar
  20. 20.
    Simon C, Gutierrez A, Vidal A, de los Santos MJ, Tarin JJ, Remohi J, Pellicer A (1994) Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod 9(4):725–729CrossRefGoogle Scholar
  21. 21.
    Romero R, Espinoza J, Mazor M (2004) Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil Steril 82(4):799–804.  https://doi.org/10.1016/j.fertnstert.2004.05.076 CrossRefGoogle Scholar
  22. 22.
    Sugita A, Iwase A, Goto M, Nakahara T, Nakamura T, Kondo M, Osuka S, Mori M, Saito A, Kikkawa F (2013) One-year follow-up of serum antimullerian hormone levels in patients with cystectomy: are different sequential changes due to different mechanisms causing damage to the ovarian reserve? Fertil Steril 100(2):516–522.e513. https://doi.org/10.1016/j.fertnstert.2013.03.032
  23. 23.
    Bennett SJ, Waterstone JJ, Cheng WC, Parsons J (1993) Complications of transvaginal ultrasound-directed follicle aspiration: a review of 2670 consecutive procedures. J Assist Reprod Genet 10(1):72–77CrossRefGoogle Scholar
  24. 24.
    Hannoun A, Awwad J, Zreik T, Ghaziri G, Abu-Musa A (2008) Effect of betadine vaginal preparation during oocyte aspiration in in vitro fertilization cycles on pregnancy outcome. Gynecol Obstet Invest 66(4):274–278.  https://doi.org/10.1159/000156378 CrossRefGoogle Scholar
  25. 25.
    van Os HC, Roozenburg BJ, Janssen-Caspers HA, Leerentveld RA, Scholtes MC, Zeilmaker GH, Alberda AT (1992) Vaginal disinfection with povidon iodine and the outcome of in-vitro fertilization. Hum Reprod 7(3):349–350CrossRefGoogle Scholar
  26. 26.
    Raffi F, Metwally M, Amer S (2012) The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab 97(9):3146–3154.  https://doi.org/10.1210/jc.2012-1558 CrossRefGoogle Scholar
  27. 27.
    Somigliana E, Arnoldi M, Benaglia L, Iemmello R, Nicolosi AE, Ragni G (2008) IVF-ICSI outcome in women operated on for bilateral endometriomas. Hum Reprod 23(7):1526–1530.  https://doi.org/10.1093/humrep/den133 CrossRefGoogle Scholar
  28. 28.
    Henzl MR, Corson SL, Moghissi K, Buttram VC, Berqvist C, Jacobson J (1988) Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N Engl J Med 318(8):485–489. https://doi.org/10.1056/NEJM198802253180805
  29. 29.
    Levine D, Kaufman L, Cuenca VG, Badawy SZ (2007) Cell growth effects of leuprolide on cultured endometrioma cells. J Reprod Med 52(7):581–584Google Scholar
  30. 30.
    Sallam HN, Garcia-Velasco JA, Dias S, Arici A (2006) Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004635.pub2

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Obstetrics and Gynecology, Affiliated to the Sackler School of Medicine, Lis Maternity Hospital, Tel Aviv Sourasky Medical CenterTel Aviv UniversityTel AvivIsrael

Personalised recommendations